Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew I Milowsky

Showing results (31-40 of 205) with videos related to

Pageof 21
Sort By:
Clinical Genitourinary Cancer|May 30, 2006
Chemotherapy for non-clear-cell renal cell carcinomaKevin A David, Matthew I Milowsky, David M Nanus
The Oncologist|July 26, 2013
Neoadjuvant paradigm for accelerated drug development: an ideal model in bladder cancerDavid D Chism, Michael E Woods, Matthew I Milowsky
Current Opinion in Urology|March 12, 2019
Perioperative systemic therapy for bladder cancerPatrick J Eulitt, Marc A Bjurlin, Matthew I Milowsky
International Braz J Urol : Official Journal of the Brazilian Society of Urology|January 22, 2020
Bladder preservation in muscle-invasive bladder cancer: a comprehensive reviewJudy Hamad, Hannah McCloskey, Matthew I Milowsky, et al.
BJU International|April 1, 2018
Modelling cost-effectiveness of a biomarker-based approach to neoadjuvant chemotherapy for muscle-invasive bladder cancerYair Lotan, Solomon L Woldu, Oner Sanli, et al.
JAMA Oncology|March 25, 2016
Intrinsic Genomic Differences Between African American and White Patients With Clear Cell Renal Cell CarcinomaBhavani Krishnan, Tracy L Rose, Jordan Kardos, et al.
Journal of Medical Case Reports|November 18, 2009
Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literatureOscar B Goodman, Matthew I Milowsky, Jodi Kaplan, et al.
Cancer|January 30, 2002
Active chemotherapy for collecting duct carcinoma of the kidney: a case report and review of the literatureMatthew I Milowsky, Alyssa Rosmarin, Satish K Tickoo, et al.
Frontiers in Oncology|September 16, 2024
PD-L1 expression and correlation with outcome in muscle-invasive and metastatic urothelial carcinoma: review and critical discussionTämer El Saadany, Anja Lorch, Matthew I Milowsky, et al.
Cancer|September 21, 2004
Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinomaDavid M Nanus, Alexandria Garino, Matthew I Milowsky, et al.
Pageof 21

Showing results (31-40 of 205) with videos related to

Sort By:
Pageof 21
Clinical Genitourinary Cancer|May 30, 2006
Chemotherapy for non-clear-cell renal cell carcinomaKevin A David, Matthew I Milowsky, David M Nanus
The Oncologist|July 26, 2013
Neoadjuvant paradigm for accelerated drug development: an ideal model in bladder cancerDavid D Chism, Michael E Woods, Matthew I Milowsky
Current Opinion in Urology|March 12, 2019
Perioperative systemic therapy for bladder cancerPatrick J Eulitt, Marc A Bjurlin, Matthew I Milowsky
International Braz J Urol : Official Journal of the Brazilian Society of Urology|January 22, 2020
Bladder preservation in muscle-invasive bladder cancer: a comprehensive reviewJudy Hamad, Hannah McCloskey, Matthew I Milowsky, et al.
BJU International|April 1, 2018
Modelling cost-effectiveness of a biomarker-based approach to neoadjuvant chemotherapy for muscle-invasive bladder cancerYair Lotan, Solomon L Woldu, Oner Sanli, et al.
JAMA Oncology|March 25, 2016
Intrinsic Genomic Differences Between African American and White Patients With Clear Cell Renal Cell CarcinomaBhavani Krishnan, Tracy L Rose, Jordan Kardos, et al.
Journal of Medical Case Reports|November 18, 2009
Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literatureOscar B Goodman, Matthew I Milowsky, Jodi Kaplan, et al.
Cancer|January 30, 2002
Active chemotherapy for collecting duct carcinoma of the kidney: a case report and review of the literatureMatthew I Milowsky, Alyssa Rosmarin, Satish K Tickoo, et al.
Frontiers in Oncology|September 16, 2024
PD-L1 expression and correlation with outcome in muscle-invasive and metastatic urothelial carcinoma: review and critical discussionTämer El Saadany, Anja Lorch, Matthew I Milowsky, et al.
Cancer|September 21, 2004
Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinomaDavid M Nanus, Alexandria Garino, Matthew I Milowsky, et al.
Pageof 21